EMRE KARA
EMRE KARA
Hacettepe University Faculty of Pharmacy, Department of Clinical Pharmacy
hacettepe.edu.tr üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
The another side of COVID-19 in Alzheimer’s disease patients: Drug-drug interactions
F Balli, E Kara, SK Demirkan
Authorea Preprints, 2020
162020
Knowledge and attitudes among hospital pharmacists about COVID-19
K Emre, K Demirkan, Ü Serhat
Turkish journal of pharmaceutical sciences 17 (3), 242, 2020
152020
Polypharmacy and drug-related problems among people living with HIV/AIDS: a single-center experience
E Kara, AÇ İnkaya, DA HAKLI, SK DEMIRKAN, S Ünal
Turkish journal of medical sciences 49 (1), 222-229, 2019
52019
May drug-related cardiovascular toxicities persist after hospital discharge in COVID-19 patients?
E Kara, AC Inkaya, K Demirkan
International journal of antimicrobial agents 55 (6), 106003, 2020
22020
Implementation of Pharmacist-driven Antifungal Stewardship Program in A Tertiary Care Hospital
E Kara, G Metan, A Bayraktar-Ekincioglu, D Gulmez, S Arikan-Akdagli, ...
Antimicrobial Agents and Chemotherapy, AAC. 00629-21, 2021
12021
Cross-Reactivity to Meropenem and Ertapenem Without Imipenem
PB EKINCI, K Emre, A Yalcin, K Demirkan, U Omrum
Journal of Critical and Intensive Care 11 (1), 28, 2020
12020
Yoğun Bakım Hastalarında Antibiyotiklerin Diğer İlaçlarla Etkileşimlerinin Değerlendirilmesi
K Emre, K Tecen-Yücel, N Özdemir, AÇ İnkaya, A Bayraktar-Ekincioğlu, ...
STED/Sürekli Tıp Eğitimi Dergisi 28 (6), 404-409, 2019
12019
Recreational Drugs and Antiretrovirals: Is it worth the world or trivial?
E Kara, AÇ Inkaya, K Demirkan, S Ünal
Mediterranean Journal of Infection Microbes and Antimicrobials 5, 2016
1*2016
Pharmacist intervention to improve patients’ knowledge and attitude towards hepatitis B infection
M Bahap, E Kara, M Cagla Sonmezer, AC Inkaya, D Aydin‐Hakli, S Unal, ...
International Journal of Clinical Practice 75 (4), e13952, 2021
2021
A case report of tigecycline induced acute pancreatitis in a renal transplant patient and review of the literature: Should we avoid tigecycline in patients on calcineurin …
B Yazirli, E Kara, AC Inkaya, S Maden, U Ozberk, T Yildirim, E Parlak, ...
Transplant Infectious Disease, e13593, 2021
2021
Might Confounding Factors Have an Effect on Suboptimal Dosing of Fluconazole in Critically Ill Patients?
E Kara, A Bayraktar Ekincioglu, G Metan
Antimicrobial agents and chemotherapy 65 (2), e02118-20, 2021
2021
Fighting on two fronts: drug–drug interactions in people living with HIV infected with SARS-CoV-2
M Bahap, E Kara, GS Guven
European Journal of Hospital Pharmacy 28 (1), e3-e3, 2021
2021
Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19
E Kara, K Demirkan, S Unal
International Journal of Antimicrobial Agents 56 (3), 106123, 2020
2020
Evaluation of internal medicine physicians’ attitudes toward the treatment of dyslipidemia
E Kara, K Tecen Yucel, A Bayraktar-Ekincioglu, K Demirkan, ...
Postgraduate medicine 132 (6), 538-543, 2020
2020
The Impact of The Clinical Pharmacist‐Led Interventions in Turkey Türkiye'de Klinik Eczacı Tarafından Yapılan Müdahalelerin Etkisi
E Kara, B Kelleci, M Sancar, K Demirkan, E Kara
2020
Should prolonged ceftriaxone infusions be preferred in septic patients?
E Kara, M Bahap, AC Inkaya
The American Journal of Emergency Medicine, 2020
2020
Drug-drug interactions in intensive care unit: A point prevalence study
M Bahap, E Kara, A Bayraktar-Ekincioglu, A Topeli, K Demirkan
2018
Evaluation of potential drug drug interactions on antiretroviral treatment
E Kara, A İNKAYA, N Ozdemir, A Bayraktar-Ekincioglu, K Demirkan, ...
2018
Are physicians confused in the management of dyslipidemia?
K Tecen, E Kara, S Ecemis, E Aras, N Ozdemir, A Bayraktar-Ekincioglu, ...
2018
Evaluation of antibiotic drug interactions in intensive care unit
E Kara, K Tecen, N Ozdemir, A İNKAYA, A Bayraktar-Ekincioglu, ...
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 39 (1), 290-291, 2017
2017
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20